Clinical Applications of Procalcitonin in Pediatrics: An Advanced Biomarker for Inflammation and Infection—Can It Also Be Used in Trauma?

Abstract

Background. Procalcitonin is a small molecular peptide that has gained increased support as an adjunct diagnostic marker of infection in the adult population; the concordant body of evidence for the use of procalcitonin in pediatric populations is far less complete. Objectives. Our objective is to review the current evidence supporting the utilization of procalcitonin in children in a variety of clinical scenarios including SIRS, sepsis, burns, and trauma and to identify existing knowledge gaps. Methods. A thorough review of the literature was performed utilizing PubMed. We focused on using meta-analysis from adult populations to review current practices in interpretation and methodology and find concordant pediatric studies to determine if the same applications are validated in pediatric populations. Results. Current evidence supports the usage of procalcitonin as both a sensitive and a specific marker for the differentiation of systemic inflammatory response syndrome from sepsis in pediatrics with increased diagnostic accuracy compared to commonly used biomarkers including complete blood counts and C-reactive protein. Conclusions. Although the body of evidence is limited, initial observations suggest that procalcitonin can be used in pediatric trauma and burn patients as both a prognostic and a diagnostic marker, aiding in the identification of infection in patients with extensive underlying inflammation.

A randomised trial on the therapeutic effectiveness of bronchoalveolar lavage under fiberoptic bronchoscopy in patients with severe lung infection living in the Tibetan plateau area

“…Therefore, our findings suggest that BAL under fiberoptic bronchoscopy can effectively relieve heavy bleeding, small airway interference, restore breathing, increase the oxygen content in the blood, and help to reduce cerebral edema, thereby accelerate the recovery. At the same time, the effectiveness of treatment in the observational group was significantly compared to the control group, suggesting that BAL can effectively improve the treatment effectiveness, which is consistent with the conclusions of previous studies (20).…”

Fever and Bone Pain Is Not Always Osteomyelitis

“…Some studies conclude that PCT is a more effective marker of infection compared with C-reactive protein because it peaks sooner and has a higher positive likelihood of infection. 5,6 Studies also suggest that PCT is elevated in patients with medullary thyroid cancer and lung cancer with neuroendocrine components and liver metastases. 7,8 A recent study suggested that patients with a PCT of 1.2 ng/mL most likely have a bacterial infection and that antibiotics should be started immediately; however, other studies fail to support this threshold.…”

Laboratory Markers in the Management of Pediatric Polytrauma: Current Role and Areas of Future Research

“…Therefore, blood samples of 30 children with acute trauma were investigated, in which 23% developed sepsis and the PCT peaked at day 2. PCT at day 2 was an independent predictor of the development of sepsis in children (39,40).…”